跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clitaxsaph-100 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clitaxsaph-100
Approved
STANDARD
Clitaxsaph-100
Bruck Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b8853aeef0539150
Company
Bruck Pharma Private Limited
Type
Standard
Approval Details
Approval Id
b8853aeef0539150
Drug Approval Philippines Name
Clitaxsaph-100
Product Name
Clitaxsaph-100
Registration Number
DRP-11218
Brand Name
Clitaxsaph-100
Generic Name
Paclitaxel
Dosage Form
Lyophilized Powder For (I.V. Infusion)
Dosage Strength
100mg
Manufacturer
Bruck Pharma Private Limited
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
27 April 2023
Expiry Date
15 February 2027
Pharmacologic Category
Antineoplastic (Taxane
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b8853aeef0539150
Type
Standard
Back to Philippines FDA Approvals